Aparajita Tyagi
Global Market Access Lead, Obesity Market Access, Novo Nordisk
Aparajita Tyagi is listed as Global Market Access Lead, Obesity Market Access, Novo Nordisk. Aparajita spoke at ISPOR Europe 2026 in November 2026 (speaker, “Beyond Healthcare Costs: Valuing Obesity Treatment for Patients, Workforces, and Society”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Aparajita. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Beyond Healthcare Costs: Valuing Obesity Treatment for Patients, Workforces, and Society Speaker · 10 November 2026
Spoke alongside
People who have shared a session with Aparajita at events on B2DB.
- Francesca Fiorentino Associate Principal - Global Health Economics · IQVIA 1 shared session
- Hanène Samouda LASO (Luxembourg Association of People Living with Obesity) 1 shared session
- Johan Fagerudd Pihlajalinna 1 shared session
Others from Novo Nordisk
- Antoine Minot Vice President, Global Security 2 sessions
- Francisco Javier Fillat Digital Health & Digital MKT Sr. Manager 2 sessions
- Julie Gerlings Sr. Responsible AI Scientist 1 session
- Tina Møller Tagmose Principal Scientist 1 session